Chapter 604
Chapter 604
Therefore, the advantages of early treatment with Elshilan anti-cancer drugs are indeed very obvious. It allows all patients to directly feel the changes in their bodies and believe that Elshilan anti-cancer drugs are the best treatment option.
But in the later stages, all patients will find that the specific medicine for lung cancer is the real cure.
If given a choice, no one would want to take medicine for a lifetime, let alone worry about drug resistance for a lifetime.
Moreover, daily medicine expenses are also a big problem. Who can guarantee that they can afford the medicine expenses for a lifetime?
However, for pharmaceutical companies, the ideal situation is to treat any disease into a chronic disease, preferably a chronic disease that cannot be cured for a lifetime but will not kill the patient.
For example, if breast cancer becomes a chronic disease and requires lifelong medication, they can make money for a lifetime without worrying about future sales, and their profits will only increase.
Especially after the patent expires, they can make a lot of money. This is the biggest pursuit of pharmaceutical companies. As long as it is possible, they will hope to treat it into a chronic disease so that these diseases require lifelong medication.
Elshilan anti-cancer drug is one of the best among them. It can treat breast cancer into a chronic disease that requires lifelong medication.
If successful, Pfizer will indeed make a fortune, and if accumulated over the years, the profits will definitely be astonishing.
Moreover, because the early treatment effects are significant, it is indeed easier to attract patients. However, they do not know that this medicine needs to be taken for a lifetime and cannot be stopped.
But the premise of all this is that it can be successful.
If you can't succeed, then everything you say is fake.
"It's meaningless to say this now."
"The side effects of Elsilan's anti-cancer drugs are too severe, and the mortality rate from long-term use is too high."
"This drug is destined not to be marketed. No matter how great its early advantages are, they will never be fully utilized."
Chen Xuan finally came to this conclusion.
He does not think that the anti-cancer drug Elshilan will pose a threat to the specific drug for lung cancer.
If the mortality rate of a drug is higher than the mortality rate of the disease itself, then basically no one will be willing to use this drug.
In this case, this drug cannot even be put on the market, so how can it compete?
Luo Shiyun nodded in agreement with Chen Xuan's words.
At the same time, she is now also looking forward to the early completion of clinical trials on lung cancer and breast cancer.
As long as a few more indications are added, the sales of lung cancer drugs will increase significantly.
Judging from the performance of lung cancer-specific drugs, there are basically no competitors in the treatment of breast cancer.
Although there are effective drugs for lung cancer treatment, breast cancer still needs to be taken for a long time and cannot be cured directly in a short time.
But for a type of cancer, being able to be cured simply by taking medicine is already very fortunate, and is also what countless patients desire most.
Even if the treatment time is a little longer, it is acceptable. No one will not receive treatment just because it takes a long time. Especially if it does not require surgery, it is even more attractive.
For example, Luo Shiyun herself is the last person who wants to have surgery right now.
If she just took medicine every day, she could treat this illness as a cold and fever and not take it too seriously.
Therefore, most other patients will choose this treatment option, and they would not want to undergo surgery as long as they have a choice.
Surgery is almost everyone's last resort, and the first choice is conservative treatment.
“When I went to the hospital for a checkup,”
"I've also been to the cancer department, and there's a long queue now."
"Most of them are lung cancer patients. They are here to buy effective drugs for lung cancer. They just need to go through a penalty before they can buy them, and they are only allowed to register and see a doctor first."
mtl008